Feasibility Study of an Interactive Wall-Based Intervention Program for Nursing Home Residents and Patients in Long-Term Care Facilities: Mur'Aventure (MUR'AVENTURE)
7 septembre 2026 mis à jour par: Centre Hospitalier Universitaire de Nice
This prospective, single-arm feasibility study aims to evaluate the feasibility of a 12-week immersive exergame program using an interactive wall in older adults living in nursing homes (EHPAD) or long-term care units (USLD).
Exergames are interactive digital games that integrate physical activity into gameplay, requiring users to perform whole-body movements to achieve game objectives while promoting exercise and energy expenditure.
Participants will complete two supervised 40-minute sessions per week over 12 weeks.
The primary objective is to assess feasibility through acceptability, adherence, and safety.
Secondary objectives include evaluating implementation fidelity, preliminary effects on cognition, quality of life and well-being, and characterizing the physical and cognitive demands of the interactive games.
Data will include usability and enjoyment questionnaires, attendance, adverse events, heart rate monitoring, cognitive performance (MoCA), quality of life (EQ-5D-5L), psychological well-being (Mini-GDS and QUALIDEM), and game performance.
The results will inform the design of a future larger-scale effectiveness trial of immersive exergaming in institutionalized older adults.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Estimé)
25
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Elodie Piche, PhD
- Numéro de téléphone: +33492034925
- E-mail: piche.e@chu-nice.fr
Sauvegarde des contacts de l'étude
- Nom: Assia Bebiche Lamali, MD
- Numéro de téléphone: +33492034925
- E-mail: bebiche-lamali.a@chu-nice.fr
Lieux d'étude
-
-
-
Nice, France
- Chu De Nice
-
Contact:
- Elodie Piche, PhD
- Numéro de téléphone: +33492034925
- E-mail: piche.e@chu-nice.fr
-
Chercheur principal:
- Assia Bebiche Lamali, MD
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Adults aged 65 years or older.
- Resident of a nursing home (EHPAD) or long-term care unit (USLD).
- Affiliated with the French national health insurance system.
- Able to participate in low-to-moderate intensity adapted physical activity.
- No cognitive impairment or mild-to-moderate cognitive impairment compatible with understanding simple instructions (MoCA >18 and physician approval).
- Written informed consent provided by the participant or legal representative.
Exclusion Criteria:
- Medical contraindication to adapted physical activity.
- Severe neurological or psychiatric disorder incompatible with safe participation.
- Severe uncorrected visual, auditory or sensory impairment preventing interaction with the immersive wall.
- Inability to understand instructions despite adaptation.
- Participation in another interventional study that may interfere with study outcomes.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Immersive Interactive Wall Exergame Program (Mur'Aventure)
|
Participants will complete a supervised 12-week adapted physical activity program delivered through an immersive interactive wall (NeoXperience).
Sessions will be performed twice weekly in groups of four participants and will last approximately 40 minutes, including a warm-up.
Games are adapted to participants' physical and cognitive abilities and combine cognitive stimulation with whole-body movements.
Heart rate, physical activity intensity, game performance, perceived exertion, fatigue and enjoyment will be monitored throughout the intervention.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Acceptability of the Mur'Aventure program assessed using the French System Usability Scale (F-SUS)
Délai: During the 12-week intervention and immediately after the intervention.
|
Acceptability will be assessed using the French version of the System Usability Scale (F-SUS), a validated 10-item questionnaire evaluating the perceived usability of a system. Total scores range from 0 to 100, with higher scores indicating greater usability and acceptability. Acceptability will be considered achieved if at least 70% of participants obtain a score >70. Feasibility will be considered successful if all three predefined feasibility criteria (acceptability, adherence, and safety) are met. If one or more criteria are not met, the feasibility of the intervention will be interpreted in light of the unmet criterion(ia), and potential modifications to the intervention or study procedures will be discussed. |
During the 12-week intervention and immediately after the intervention.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Program adherence : predefined feasibility criteria
Délai: Throughout the 12-week intervention.
|
Adherence will be evaluated by the completion rate, defined as the proportion of participants completing the entire 12-week intervention.
Adherence will be considered good if the completion rate is ≥70%.
Attendance rate and dropout rate will also be reported descriptively.
|
Throughout the 12-week intervention.
|
|
Safety of the Mur'Aventure program : predefined feasibility criteria
Délai: Throughout the 12-week intervention
|
Safety will be assessed by recording the occurrence of serious adverse events (SAEs) throughout the intervention.
Safety will be considered acceptable if no serious adverse events related to the intervention occur.
Additional descriptive safety measures include perceived fatigue, perceived exertion, and heart rate responses recorded during each intervention session.
|
Throughout the 12-week intervention
|
|
Intervention fidelity
Délai: Throughout the 12-week intervention
|
To describe the fidelity of program implementation, assessed by the proportion of intervention sessions delivered according to the planned protocol Intervention fidelity will be assessed as the percentage of planned exercise sessions completed according to the study protocol.
Higher percentages indicate greater fidelity to the intervention.
|
Throughout the 12-week intervention
|
|
Change in Montreal Cognitive Assessment (MoCA) total score
Délai: Baseline and immediately after the 12-week intervention
|
To explore the preliminary effects of the program on cognitive function, assessed by the change in the Montreal Cognitive Assessment (MoCA) total score Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a validated 30-point cognitive screening instrument evaluating memory, executive function, attention, language, visuospatial abilities, abstraction, and orientation.
Scores range from 0 to 30, with higher scores indicating better cognitive function.
The outcome is the change in total score between baseline and the end of the intervention.
|
Baseline and immediately after the 12-week intervention
|
|
Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L) score
Délai: Baseline and immediately after the 12-week intervention
|
To explore the preliminary effects of the program on health-related quality of life, assessed by the change in the EuroQol 5-Dimension 5-Level (EQ-5D-5L) score from baseline to post-intervention. Health-related quality of life will be assessed using the EQ-5D-5L questionnaire, which evaluates mobility, self-care, usual activities, pain/discomfort, and anxiety/depression across five severity levels. Responses are converted into an EQ-5D index value, with higher index values indicating better health-related quality of life. The change in EQ-5D index score between baseline and the end of the intervention will be analyzed |
Baseline and immediately after the 12-week intervention
|
|
Change in Mini-Geriatric Depression Scale (Mini-GDS) score
Délai: Baseline and immediately after the 12-week intervention.
|
To explore the preliminary effects of the program on self-reported psychological well-being, assessed by the change in the 4-item Mini-Geriatric Depression Scale (Mini-GDS) score from baseline to post-intervention. Psychological well-being will be assessed using the 4-item Mini-Geriatric Depression Scale (Mini-GDS). Scores range from 0 to 4, with higher scores indicating more depressive symptoms and poorer psychological well-being. The outcome is the change in total score between baseline and the end of the intervention |
Baseline and immediately after the 12-week intervention.
|
|
Change in QUALIDEM total score
Délai: Baseline and immediately after the 12-week intervention.
|
To explore the preliminary effects of the program on caregiver-observed well-being, assessed by the change in the French version of the QUALIDEM total score from baseline to post-intervention. Observed well-being will be assessed using the French version of the QUALIDEM questionnaire, a proxy-rated instrument evaluating quality of life in older adults with cognitive impairment. Higher score indicating better quality of life. The outcome is the change in total score between baseline and the end of the intervention. |
Baseline and immediately after the 12-week intervention.
|
|
Mean heart rate during intervention sessions
Délai: During each intervention session throughout the 12-week intervention.
|
To describe the physical stimulation induced by the intervention sessions, assessed using heart rate and measured during each session with the Polar Unite wearable device Heart rate will be continuously recorded during each exercise session using a Polar Unite heart rate monitor.
Mean heart rate (beats per minute) as well as maximal heart rate will be calculated for each participant during each session.
Higher values indicate greater cardiovascular response to exercise.
|
During each intervention session throughout the 12-week intervention.
|
|
Cognitive stimulation during the intervention
Délai: During each intervention session throughout the 12-week intervention
|
To describe cognitive stimulation during the intervention, assessed using the game score, number of errors, and completion time automatically recorded during each session Cognitive stimulation will be assessed using the total score, number of errors and completion time automatically recorded by the Mur'Aventure interactive wall software during each exercise session.
Higher scores indicate better cognitive stimulation.
|
During each intervention session throughout the 12-week intervention
|
|
Mean physical load during intervention sessions
Délai: During each intervention session throughout the 12-week intervention.
|
To describe the physical stimulation induced by the intervention sessions, assessed using heart rate and physical load measured during each session with the Polar Unite wearable device Physical load will be estimated using the Polar Unite wearable device.
The device provides a proprietary estimate of exercise load based on heart rate and movement data recorded during each session.
Higher values indicate greater physical exercise load.
|
During each intervention session throughout the 12-week intervention.
|
|
Game engagement during the intervention
Délai: During each intervention session throughout the 12-week intervention
|
To describe game engagement during the intervention, assessed using the game score, number of errors, and completion time automatically recorded during each session Game engagement will be assessed using the total score, number of errors and completion time automatically recorded by the Mur'Aventure interactive wall software during each exercise session.
Higher scores indicate better game performance.
|
During each intervention session throughout the 12-week intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 octobre 2026
Achèvement primaire (Estimé)
1 janvier 2028
Achèvement de l'étude (Estimé)
1 septembre 2028
Dates d'inscription aux études
Première soumission
23 juillet 2026
Première soumission répondant aux critères de contrôle qualité
7 septembre 2026
Première publication (Réel)
9 septembre 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
9 septembre 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
7 septembre 2026
Dernière vérification
1 septembre 2026
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- [25-AOIP-06
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .